172 related articles for article (PubMed ID: 36419107)
21. The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases?
Hirbe AC; Morgan EA; Weilbaecher KN
Curr Pharm Des; 2010; 16(11):1284-90. PubMed ID: 20166978
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma.
Yang Z; Yin L; Zeng Y; Li Y; Chen H; Yin S; Zhang F; Yang W
Virchows Arch; 2021 Nov; 479(5):947-959. PubMed ID: 34148127
[TBL] [Abstract][Full Text] [Related]
23. Expression of SNCG, MAP2, SDF-1 and CXCR4 in gastric adenocarcinoma and their clinical significance.
Zheng S; Shi L; Zhang Y; He T
Int J Clin Exp Pathol; 2014; 7(10):6606-15. PubMed ID: 25400739
[TBL] [Abstract][Full Text] [Related]
24. CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer.
Stanisavljević L; Aßmus J; Storli KE; Leh SM; Dahl O; Myklebust MP
Tumour Biol; 2016 Jun; 37(6):7441-52. PubMed ID: 26678887
[TBL] [Abstract][Full Text] [Related]
25. CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells.
Hwang JH; Hwang JH; Chung HK; Kim DW; Hwang ES; Suh JM; Kim H; You KH; Kwon OY; Ro HK; Jo DY; Shong M
J Clin Endocrinol Metab; 2003 Jan; 88(1):408-16. PubMed ID: 12519884
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of HIF-2α, TWIST, and CXCR4 is associated with lymph node metastasis in papillary thyroid carcinoma.
Wang N; Luo HJ; Yin GB; Dong CR; Xu M; Chen GG; Liu ZM
Clin Dev Immunol; 2013; 2013():589423. PubMed ID: 24288553
[TBL] [Abstract][Full Text] [Related]
27. Expression of stromal cell-derived factor 1 and CXCR7 in papillary thyroid carcinoma.
Liu Z; Sun DX; Teng XY; Xu WX; Meng XP; Wang BS
Endocr Pathol; 2012 Dec; 23(4):247-53. PubMed ID: 23070788
[TBL] [Abstract][Full Text] [Related]
28. CXCR4 expression in papillary thyroid carcinoma: induction by nitric oxide and correlation with lymph node metastasis.
Yasuoka H; Kodama R; Hirokawa M; Takamura Y; Miyauchi A; Sanke T; Nakamura Y
BMC Cancer; 2008 Sep; 8():274. PubMed ID: 18826577
[TBL] [Abstract][Full Text] [Related]
29. The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma.
Almofti A; Uchida D; Begum NM; Tomizuka Y; Iga H; Yoshida H; Sato M
Int J Oncol; 2004 Jul; 25(1):65-71. PubMed ID: 15201990
[TBL] [Abstract][Full Text] [Related]
30. Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis.
Iwasa S; Yanagawa T; Fan J; Katoh R
Anticancer Res; 2009 Nov; 29(11):4751-8. PubMed ID: 20032431
[TBL] [Abstract][Full Text] [Related]
31. Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph-node-positive lung cancer patients.
Katsura M; Shoji F; Okamoto T; Shimamatsu S; Hirai F; Toyokawa G; Morodomi Y; Tagawa T; Oda Y; Maehara Y
Cancer Sci; 2018 Jan; 109(1):154-165. PubMed ID: 29032612
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of SDF-1/CXCR4 is associated with lymph node metastasis of invasive micropapillary carcinoma of the breast.
Liu F; Lang R; Wei J; Fan Y; Cui L; Gu F; Guo X; Pringle GA; Zhang X; Fu L
Histopathology; 2009 May; 54(6):741-50. PubMed ID: 19438749
[TBL] [Abstract][Full Text] [Related]
33. Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer.
Zhu X; Bai Q; Lu Y; Lu Y; Zhu L; Zhou X; Wu L
Int J Oncol; 2016 Jun; 48(6):2321-9. PubMed ID: 27082011
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic silencing of CXCR4 promotes loss of cell adhesion in cervical cancer.
Yadav SS; Prasad SB; Das M; Kumari S; Pandey LK; Singh S; Pradhan S; Narayan G
Biomed Res Int; 2014; 2014():581403. PubMed ID: 25114911
[TBL] [Abstract][Full Text] [Related]
35. Involvement of SDF-1alpha/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma.
Kajiyama H; Shibata K; Terauchi M; Ino K; Nawa A; Kikkawa F
Int J Cancer; 2008 Jan; 122(1):91-9. PubMed ID: 17893878
[TBL] [Abstract][Full Text] [Related]
36. LRP6 Ectodomain Prevents SDF-1/CXCR4-Induced Breast Cancer Metastasis to Lung.
Zhang J; Chen J; Wo D; Yan H; Liu P; Ma E; Li L; Zheng L; Chen D; Yu Z; Liang C; Peng J; Ren DN; Zhu W
Clin Cancer Res; 2019 Aug; 25(15):4832-4845. PubMed ID: 31010839
[TBL] [Abstract][Full Text] [Related]
37. Well-differentiated thyroid cancer with a minor poorly differentiated component: clonal heterogeneity through the prognostic role of CXCR4 and BRAF analysis.
Rossi ED; Martini M; Capodimonti S; Straccia P; Revelli L; Lombardi CP; Pontecorvi A; Santeusanio G; Larocca LM; Fadda G
Appl Immunohistochem Mol Morphol; 2015 Mar; 23(3):196-201. PubMed ID: 24992171
[TBL] [Abstract][Full Text] [Related]
38. CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma.
Werner TA; Forster CM; Dizdar L; Verde PE; Raba K; Schott M; Knoefel WT; Krieg A
Br J Cancer; 2017 Dec; 117(12):1837-1845. PubMed ID: 29112684
[TBL] [Abstract][Full Text] [Related]
39. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
[TBL] [Abstract][Full Text] [Related]
40. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B
Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
